Evidence map›Paper›PMID 29940136›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2018

The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.

Zachary Klaassen, Christopher J D Wallis, Hanan Goldberg, Thenappan Chandrasekar, Neil E Fleshner, Antonio Finelli, Girish S Kulkarni, Allan S Detsky, Raj Satkunasivam

Abstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zachary KlaassenPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Christopher J D WallisPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Hanan GoldbergPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Thenappan ChandrasekarPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Neil E FleshnerPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Antonio FinelliPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Girish S KulkarniPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Allan S DetskyPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Raj SatkunasivamPrincess Margaret Cancer Centre, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionShared decision-making is widely recommended when men are considering prostate cancer screening with prostate-specific antigen (PSA). The role of patients' trust in cancer information from their physician in such decisions is unknown.

methodsWe identified male respondents ≥18 years of age from the Health Information National Trends Survey, a population-based survey of people living in the U.S. (2011-014). We assessed the association between degree of trust in cancer information from respondent's physician with patient-reported receipt of PSA-screening and patient-reported discussion of PSA screening with their physician.

resultsAmong 5069 eligible respondents, 3606 (71.1%) men reported trusting cancer information from their physician "a lot," 1186 (23.4%) "somewhat," 219 (4.3%) "a little," and 58 (1.1%) "not at all." A total of 2655 (52.4%) men reported receiving PSA screening. The degree of trust an individual had in his physician for cancer information was strongly associated with his likelihood of having received PSA screening (p

conclusionsThe level of trust an individual has in cancer information from his physician is strongly associated with his likelihood of discussing and undergoing PSA screening. As rationale, implementation of PSA screening requires shared decision-making, and the level of trust an individual has in his physician has important implications for dissemination of PSA screening guidelines.

Identifiers

PMID29940136
PMCPMC6261724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.